| Application no. and date | 12831010.9 (espacenet) (Federated) (European Patent Register), 20120912 | | Patent/reg. no. and date | DK/EP 2755675, 20180606 | | Publication date | 20140723 | | Priority no. and date | US 201161573748 P, 20110912 | | EP pub. no. and date |
EP 2755675 20140723 | | Effective date | | | Applicant/owner | Amunix Pharmaceuticals, Inc., 500 Ellis Street
Mountainview, CA 94043, US | | Applicant ref. no. | P81802429DK00E | | Inventor | Schellenberger, Volker, 914 Moreno Avenue
Palo Alto, CA 94303, US,
Silverman, Joshua,
829 Dartshire Way
Sunnyvale, CA 94087, US,
WANG, Chia-wei, 1449 David Lane
Milpitas, CA 95035, US,
GEETHING, Nathan, 2009 Garzoni Place
Santa Clara, CA 95054, US,
SPINK, Benjamin, 379 Northam Avenue
San Carlos, CA 94070, US,
STEMMER, Willem P., 108 Kathy Court
Los Gatos, CA 95051, US | | Representative | Zacco Denmark A/S, Arne Jacobsens Allé 15, 2300 København S | | Opponent | | | IPC Class | A61K 38/26 (2006.01) , C07K 14/605 (2006.01) | | Title | Glucagonlignende peptid-2-sammensætninger og fremgangsmåder til fremstilling og anvendelse deraf | | Int. application no. | US2012054941 | | Int. publication no. | WO2013040093 | | Related patent (certificate) | | | Status | DK/EP patent | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
